California Public Employees Retirement System’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-135,360
Closed -$3.59M 1143
2025
Q2
$3.59M Buy
135,360
+11,349
+9% +$299K ﹤0.01% 1081
2025
Q1
$2.99M Sell
124,011
-12,581
-9% -$398K ﹤0.01% 1093
2024
Q4
$5.5M Sell
136,592
-47,576
-26% -$2.71M ﹤0.01% 1041
2024
Q3
$11.7M Buy
+184,168
New +$10.8M 0.01% 841
2021
Q2
Sell
-133,300
Closed -$843K 2885
2021
Q1
$843K Hold
133,300
﹤0.01% 2607
2020
Q4
$750K Sell
133,300
-2,800
-2% -$17K ﹤0.01% 2667
2020
Q3
$792K Buy
136,100
+3,400
+3% +$23.4K ﹤0.01% 2451
2020
Q2
$957K Buy
132,700
+400
+0.3% +$2.66K ﹤0.01% 2272
2020
Q1
$619K Buy
132,300
+20,900
+19% +$128K ﹤0.01% 2287
2019
Q4
$893K Buy
111,400
+91,900
+471% +$670K ﹤0.01% 2437
2019
Q3
$134K Sell
19,500
-791
-4% -$5.88K ﹤0.01% 3042
2019
Q2
$168K Buy
20,291
+8,300
+69% +$70.9K ﹤0.01% 2975
2019
Q1
$119K Buy
+11,991
New +$100K ﹤0.01% 3029

Other funds holding VKTX

California Public Employees Retirement System's VKTX Position: Q3 2025 in Review

California Public Employees Retirement System sold out of Viking Therapeutics (VKTX) in Q3 2025, closing a stake of 135,360 shares — an estimated $3.59M sold.

California Public Employees Retirement System first reported a position in VKTX in Q1 2019 and held it in 13 quarters. The position peaked at $11.7M in Q3 2024. 370 funds tracked by Wall St. Rank hold VKTX as of Q3 2025.

  • California Public Employees Retirement System reported no remaining Viking Therapeutics position as of Q3 2025 after selling out during the quarter.
  • California Public Employees Retirement System sold 135,360 Viking Therapeutics shares in Q3 2025, an estimated $3.59M.
  • California Public Employees Retirement System first reported a position in Viking Therapeutics in Q1 2019 and held it in 13 quarters.
  • California Public Employees Retirement System's Viking Therapeutics position peaked at $11.7M in Q3 2024.
  • 370 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2025.

Based on California Public Employees Retirement System's 13F filing for Q3 2025, filed 14 Nov 2025.